Key Points
- Omada Health CFO Steven Cook sold 6,800 shares on June 15 at an average price of $17.23, totaling $117,164. After the sale, he still held 187,209 shares, a 3.5% reduction in his position.
- The company recently reported quarterly earnings of -$0.05 per share, beating expectations of -$0.08, on revenue of $78.05 million. Analysts currently expect Omada Health to post roughly breakeven earnings for the full fiscal year.
- Analyst sentiment remains broadly positive, with an average rating of “Moderate Buy” and an average price target of $22.91. Several firms recently raised targets, including Barclays, Citizens JMP, and Evercore.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) President Wei-Li Shao sold 4,589 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $17.24, for a total value of $79,114.36. Following the transaction, the president owned 316,238 shares of the company's stock, valued at approximately $5,451,943.12. This trade represents a 1.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Wei-Li Shao also recently made the following trade(s):
- On Wednesday, April 8th, Wei-Li Shao sold 2,829 shares of Omada Health stock. The shares were sold at an average price of $12.71, for a total value of $35,956.59.
Omada Health Trading Down 1.3%
Omada Health stock opened at $17.11 on Wednesday. The stock has a market cap of $1.02 billion and a P/E ratio of -63.37. The stock has a 50 day moving average of $15.54 and a 200-day moving average of $14.80. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.
Omada Health (NASDAQ:OMDA - Get Free Report) last released its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, equities analysts predict that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Omada Health
Large investors have recently added to or reduced their stakes in the company. Quarry LP bought a new position in Omada Health during the fourth quarter worth $29,000. TD Waterhouse Canada Inc. bought a new position in Omada Health during the fourth quarter worth $32,000. Raymond James Financial Inc. bought a new position in Omada Health during the second quarter worth $32,000. Inlight Wealth Management LLC bought a new position in Omada Health during the fourth quarter worth $45,000. Finally, Strs Ohio lifted its stake in Omada Health by 151.0% during the fourth quarter. Strs Ohio now owns 4,267 shares of the company's stock worth $67,000 after purchasing an additional 2,567 shares during the last quarter.
Analysts Set New Price Targets
Several research firms have recently commented on OMDA. Barclays increased their target price on Omada Health from $18.00 to $20.00 and gave the company an "overweight" rating in a research note on Friday, May 8th. Wells Fargo & Company increased their target price on Omada Health from $17.00 to $18.00 and gave the company an "equal weight" rating in a research note on Friday, May 8th. Citigroup reiterated an "outperform" rating on shares of Omada Health in a research note on Friday, May 8th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Omada Health in a research note on Thursday, June 4th. Finally, Canaccord Genuity Group set a $24.00 price objective on Omada Health in a research note on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $22.91.
Check Out Our Latest Analysis on Omada Health
About Omada Health
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
